1. Tfelt-Hansen PC (2013) Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 80: 869-870. doi:10.1212/01.wnl.0000427909.23467.39.
2. Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A et al. (2015) Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache 55 Suppl 4: 221-235. doi:10.1111/head.12601.
3. Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I et al. (2018) Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study. Neurology 91: e364-e373. doi:10.1212/wnl.0000000000005857.
4. Sadler RM, Purdy RA ,Rahey S (2002) Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia 22: 482-484.
5. Cecchini AP, Mea E, Tullo V, Curone M, Franzini A, Broggi G et al. (2009) Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 30 Suppl 1: S101-104. doi:10.1007/s10072-009-0073-3.
6. Goadsby PJ, Grosberg BM, Mauskop A, Cady R ,Simmons KA (2014) Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia 34: 986-993. doi:10.1177/0333102414524494.
7. Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E ,Bussone G (2015) Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain 16: 61. doi:10.1186/s10194-015-0542-4.
8. Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S et al. (2016) Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology 87: 529-538. doi:10.1212/wnl.0000000000002918.
9. Diener HC, Goadsby PJ, Ashina M, Al-Karagholi MA, Sinclair A, Mitsikostas D et al. (2019) Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia 39: 1475-1487. doi:10.1177/0333102419876920.
10. Grazzi L, Egeo G, Calhoun AH, McClure CK, Liebler E ,Barbanti P (2016) Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache Pain 17: 91. doi:10.1186/s10194-016-0684-z.
11. Grazzi L, Egeo G, Liebler E, Padovan AM ,Barbanti P (2017) Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurol Sci 38: 197-199. doi:10.1007/s10072-017-2942-5.
12. Chen SP, Ay I, de Morais AL, Qin T, Zheng Y, Sadeghian H et al. (2016) Vagus nerve stimulation inhibits cortical spreading depression. Pain 157: 797-805. doi:10.1097/j.pain.0000000000000437.
13. Ayata C (2010) Cortical spreading depression triggers migraine attack: pro. Headache 50: 725-730. doi:10.1111/j.1526-4610.2010.01647.x.
14. Ayata C, Jin H, Kudo C, Dalkara T ,Moskowitz MA (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59: 652-661. doi:10.1002/ana.20778.
15. Costa C, Tozzi A, Rainero I, Cupini LM, Calabresi P, Ayata C et al. (2013) Cortical spreading depression as a target for anti-migraine agents. J Headache Pain 14: 62. doi:10.1186/1129-2377-14-62.
16. Morais A, Liu TT, Qin T, Sadhegian H, Ay I, Yagmur D et al. (2020) Vagus nerve stimulation inhibits cortical spreading depression exclusively through central mechanisms. Pain 161: 1661-1669. doi:10.1097/j.pain.0000000000001856.
17. Shen PP, Hou S, Ma D, Zhao MM, Zhu MQ, Zhang JD et al. (2016) Cortical spreading depression-induced preconditioning in the brain. Neural Regen Res 11: 1857-1864. doi:10.4103/1673-5374.194759.
18. Fioravanti B, Kasasbeh A, Edelmayer R, Skinner DP, Jr., Hartings JA, Burklund RD et al. (2011) Evaluation of cutaneous allodynia following induction of cortical spreading depression in freely moving rats. Cephalalgia 31: 1090-1100. doi:10.1177/0333102411410609.
19. Muramatsu H, Karikó K ,Welsh FA (2004) Induction of tolerance to focal ischemia in rat brain: dissociation between cortical lesioning and spreading depression. J Cereb Blood Flow Metab 24: 1167-1171. doi:10.1097/01.wcb.0000134714.38679.2c.
20. Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M ,Burstein R (2011) Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 69: 855-865. doi:10.1002/ana.22329.
21. Takizawa T, Qin T, Lopes de Morais A, Sugimoto K, Chung JY, Morsett L et al. (2020) Non-invasively triggered spreading depolarizations induce a rapid pro-inflammatory response in cerebral cortex. J Cereb Blood Flow Metab 40: 1117-1131. doi:10.1177/0271678x19859381.
22. Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Koçak E, Sen ZD et al. (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339: 1092-1095. doi:10.1126/science.1231897.
23. Suzuki T, Takizawa T, Kamio Y, Qin T, Hashimoto T, Fujii Y et al. (2019) Noninvasive Vagus Nerve Stimulation Prevents Ruptures and Improves Outcomes in a Model of Intracranial Aneurysm in Mice. Stroke 50: 1216-1223. doi:10.1161/strokeaha.118.023928.
24. De Herdt V, De Waele J, Raedt R, Wyckhuys T, El Tahry R, Vonck K et al. (2010) Modulation of seizure threshold by vagus nerve stimulation in an animal model for motor seizures. Acta Neurol Scand 121: 271-276. doi:10.1111/j.1600-0404.2009.01223.x.
25. Vacca A, Gai A, Govone F, Rubino E, De Martino P, Gentile S et al. (2018) Noninvasive Vagal Nerve Stimulation in Chronic Migraine with Medication Overuse Headache. Pain Med 19: 2575-2577. doi:10.1093/pm/pny084.
26. Borland MS, Engineer CT, Vrana WA, Moreno NA, Engineer ND, Vanneste S et al. (2018) The Interval Between VNS-Tone Pairings Determines the Extent of Cortical Map Plasticity. Neuroscience 369: 76-86. doi:10.1016/j.neuroscience.2017.11.004.
27. Kinfe TM, Pintea B, Muhammad S, Zaremba S, Roeske S, Simon BJ et al. (2015) Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study. J Headache Pain 16: 101. doi:10.1186/s10194-015-0582-9.
28. Hays SA, Khodaparast N, Ruiz A, Sloan AM, Hulsey DR, Rennaker RL, 2nd et al. (2014) The timing and amount of vagus nerve stimulation during rehabilitative training affect poststroke recovery of forelimb strength. Neuroreport 25: 676-682. doi:10.1097/wnr.0000000000000154.
29. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ ,Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27: 107-144. doi:10.1146/annurev.neuro.27.070203.144206.
30. Richter F, Mikulik O, Ebersberger A ,Schaible HG (2005) Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage. J Cereb Blood Flow Metab 25: 1225-1235. doi:10.1038/sj.jcbfm.9600120.
31. Groves DA, Bowman EM ,Brown VJ (2005) Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 379: 174-179. doi:10.1016/j.neulet.2004.12.055.
32. Krahl SE, Senanayake SS ,Handforth A (2001) Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 42: 586-589.
33. Van Bockstaele EJ, Peoples J ,Telegan P (1999) Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J Comp Neurol 412: 410-428.
34. Herbert H ,Saper CB (1992) Organization of medullary adrenergic and noradrenergic projections to the periaqueductal gray matter in the rat. J Comp Neurol 315: 34-52. doi:10.1002/cne.903150104.
35. Cunningham JT, Mifflin SW, Gould GG ,Frazer A (2008) Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology 33: 1884-1895. doi:10.1038/sj.npp.1301570.
36. Dorr AE ,Debonnel G (2006) Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 318: 890-898. doi:10.1124/jpet.106.104166.
37. Shin HC, Jo BG, Lee CY, Lee KW ,Namgung U (2019) Hippocampal activation of 5-HT1B receptors and BDNF production by vagus nerve stimulation in rats under chronic restraint stress. Eur J Neurosci 50: 1820-1830. doi:10.1111/ejn.14368.
38. Miyamoto O, Pang J, Sumitani K, Negi T, Hayashida Y ,Itano T (2003) Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus. Neuroreport 14: 1971-1974. doi:10.1097/01.wnr.0000091686.94870.61.
39. Chen SP, Qin T, Seidel JL, Zheng Y, Eikermann M, Ferrari MD et al. (2017) Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation. Brain 140: 1643-1656. doi:10.1093/brain/awx085.
40. Yisarakun W, Chantong C, Supornsilpchai W, Thongtan T, Srikiatkhachorn A, Reuangwechvorachai P et al. (2015) Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model. Neuropeptides 51: 9-16. doi:https://doi.org/10.1016/j.npep.2015.03.008.
41. Hawkins JL, Cornelison LE, Blankenship BA ,Durham PL (2017) Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine. Pain Rep 2: e628. doi:10.1097/pr9.0000000000000628.
42. Durham PL ,Russo AF (1998) Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol Endocrinol 12: 1002-1009. doi:10.1210/mend.12.7.0135.
43. Bohotin C, Scholsem M, Multon S, Martin D, Bohotin V ,Schoenen J (2003) Vagus nerve stimulation in awake rats reduces formalin-induced nociceptive behaviour and fos-immunoreactivity in trigeminal nucleus caudalis. Pain 101: 3-12. doi:10.1016/s0304-3959(02)00301-9.
44. Cornelison LE, Woodman SE ,Durham PL (2020) Inhibition of Trigeminal Nociception by Non-invasive Vagus Nerve Stimulation: Investigating the Role of GABAergic and Serotonergic Pathways in a Model of Episodic Migraine. Frontiers in neurology 11: 146. doi:10.3389/fneur.2020.00146.
45. Yaghouby F, Jang K, Hoang U, Asgari S ,Vasudevan S (2020) Sex Differences in Vagus Nerve Stimulation Effects on Rat Cardiovascular and Immune Systems. Front Neurosci 14: 560668. doi:10.3389/fnins.2020.560668.
46. Li ST, Chiu NC, Hung KL, Ho CS, Kuo YT ,Wu WH (2020) Therapeutic effects of children with refractory epilepsy after vagus nerve stimulation in Taiwan. Pediatr Neonatol 61: 606-612. doi:10.1016/j.pedneo.2020.07.010.